Hmdb loader
Record Information
Version5.0
StatusDetected and Quantified
Creation Date2006-05-22 15:12:03 UTC
Update Date2022-03-07 02:49:16 UTC
HMDB IDHMDB0002685
Secondary Accession Numbers
  • HMDB02685
Metabolite Identification
Common NameProstaglandin F1a
DescriptionProstaglandin F1a is derived mainly from Prostaglandin E1, and is metabolized to 6-Keto Prostaglandin F1a. Prostaglandin F1a is excreted directly into the urine. Prostaglandin F1a contracts the circular muscle of the gut in opposition to the Prostaglandins of the E series. Prostaglandin F1a is a cytoprotector, protecting mucosal tissue from damage produced by ulcerogenic stimuli.Prostaglandins are eicosanoids. The eicosanoids consist of the prostaglandins (PGs), thromboxanes (TXs), leukotrienes (LTs), and lipoxins (LXs). The PGs and TXs are collectively identified as prostanoids. Prostaglandins were originally shown to be synthesized in the prostate gland, thromboxanes from platelets (thrombocytes), and leukotrienes from leukocytes, hence the derivation of their names. All mammalian cells except erythrocytes synthesize eicosanoids. These molecules are extremely potent, able to cause profound physiological effects at very dilute concentrations. All eicosanoids function locally at the site of synthesis, through receptor-mediated G-protein linked signalling pathways.
Structure
Data?1582752253
Synonyms
ValueSource
(13E,15S)-9alpha,11alpha-9,11,15-Trihydroxyprost-13-en-1-Oic acidChEBI
PGF 1-alphaChEBI
Prostaglandin F1ChEBI
Prostaglandin F1-alphaChEBI
(13E,15S)-9a,11a-9,11,15-Trihydroxyprost-13-en-1-OateGenerator
(13E,15S)-9a,11a-9,11,15-Trihydroxyprost-13-en-1-Oic acidGenerator
(13E,15S)-9alpha,11alpha-9,11,15-Trihydroxyprost-13-en-1-OateGenerator
(13E,15S)-9Α,11α-9,11,15-trihydroxyprost-13-en-1-OateGenerator
(13E,15S)-9Α,11α-9,11,15-trihydroxyprost-13-en-1-Oic acidGenerator
PGF 1-aGenerator
PGF 1-ΑGenerator
Prostaglandin F1-aGenerator
Prostaglandin F1-αGenerator
3,5-Dihydroxy-2-(3-hydroxy-1-octenyl)- (8ci)-cyclopentaneheptanoateHMDB
3,5-Dihydroxy-2-(3-hydroxy-1-octenyl)- (8ci)-cyclopentaneheptanoic acidHMDB
9a,11a,15(S)-Trihydroxy-13-trans-prostenoateHMDB
9a,11a,15(S)-Trihydroxy-13-trans-prostenoic acidHMDB
Prostaglandin F1alphaHMDB, MeSH
PGF1MeSH, HMDB
Prostaglandin F1, (9alpha,11beta,13E,15S)-isomerMeSH, HMDB
PGF1alphaMeSH, HMDB
PGF1 alphaMeSH, HMDB
Prostaglandin F1, (9alpha,11alpha,13E,15S)-(+-)-isomerMeSH, HMDB
Prostaglandin F1, (8beta,9alpha,11alpha,13E,15S)-isomerMeSH, HMDB
Prostaglandin F1, (9alpha,11alpha,13E,15R)-isomerMeSH, HMDB
PGF1aGenerator, HMDB
PGF1ΑGenerator, HMDB
Chemical FormulaC20H36O5
Average Molecular Weight356.4968
Monoisotopic Molecular Weight356.256274262
IUPAC Name7-[(1R,2R,3R,5S)-3,5-dihydroxy-2-[(1E,3S)-3-hydroxyoct-1-en-1-yl]cyclopentyl]heptanoic acid
Traditional Nameprostaglandin f1α
CAS Registry Number745-62-0
SMILES
CCCCC[C@H](O)\C=C\[C@H]1[C@H](O)C[C@H](O)[C@@H]1CCCCCCC(O)=O
InChI Identifier
InChI=1S/C20H36O5/c1-2-3-6-9-15(21)12-13-17-16(18(22)14-19(17)23)10-7-4-5-8-11-20(24)25/h12-13,15-19,21-23H,2-11,14H2,1H3,(H,24,25)/b13-12+/t15-,16+,17+,18-,19+/m0/s1
InChI KeyDZUXGQBLFALXCR-CDIPTNKSSA-N
Chemical Taxonomy
Description Belongs to the class of organic compounds known as prostaglandins and related compounds. These are unsaturated carboxylic acids consisting of a 20 carbon skeleton that also contains a five member ring, and are based upon the fatty acid arachidonic acid.
KingdomOrganic compounds
Super ClassLipids and lipid-like molecules
ClassFatty Acyls
Sub ClassEicosanoids
Direct ParentProstaglandins and related compounds
Alternative Parents
Substituents
  • Prostaglandin skeleton
  • Long-chain fatty acid
  • Fatty alcohol
  • Hydroxy fatty acid
  • Cyclopentanol
  • Cyclic alcohol
  • Secondary alcohol
  • Monocarboxylic acid or derivatives
  • Carboxylic acid
  • Carboxylic acid derivative
  • Hydrocarbon derivative
  • Organooxygen compound
  • Organic oxide
  • Alcohol
  • Organic oxygen compound
  • Carbonyl group
  • Aliphatic homomonocyclic compound
Molecular FrameworkAliphatic homomonocyclic compounds
External Descriptors
Ontology
Physiological effectNot Available
Disposition
Process
Role
Physical Properties
StateSolid
Experimental Molecular Properties
PropertyValueReference
Melting PointNot AvailableNot Available
Boiling PointNot AvailableNot Available
Water SolubilityNot AvailableNot Available
LogPNot AvailableNot Available
Experimental Chromatographic PropertiesNot Available
Predicted Molecular Properties
PropertyValueSource
Water Solubility0.11 g/LALOGPS
logP3.95ALOGPS
logP2.97ChemAxon
logS-3.5ALOGPS
pKa (Strongest Acidic)4.41ChemAxon
pKa (Strongest Basic)-1.6ChemAxon
Physiological Charge-1ChemAxon
Hydrogen Acceptor Count5ChemAxon
Hydrogen Donor Count4ChemAxon
Polar Surface Area97.99 ŲChemAxon
Rotatable Bond Count13ChemAxon
Refractivity99.35 m³·mol⁻¹ChemAxon
Polarizability42.53 ųChemAxon
Number of Rings1ChemAxon
BioavailabilityYesChemAxon
Rule of FiveYesChemAxon
Ghose FilterYesChemAxon
Veber's RuleNoChemAxon
MDDR-like RuleNoChemAxon
Predicted Chromatographic Properties

Predicted Collision Cross Sections

PredictorAdduct TypeCCS Value (Å2)Reference
DarkChem[M+H]+187.37631661259
DarkChem[M-H]-188.8331661259
DeepCCS[M+H]+201.16830932474
DeepCCS[M-H]-198.77330932474
DeepCCS[M-2H]-233.00330932474
DeepCCS[M+Na]+207.78930932474
AllCCS[M+H]+196.132859911
AllCCS[M+H-H2O]+193.532859911
AllCCS[M+NH4]+198.532859911
AllCCS[M+Na]+199.132859911
AllCCS[M-H]-193.032859911
AllCCS[M+Na-2H]-194.232859911
AllCCS[M+HCOO]-195.732859911

Predicted Retention Times

Underivatized

Chromatographic MethodRetention TimeReference
Measured using a Waters Acquity ultraperformance liquid chromatography (UPLC) ethylene-bridged hybrid (BEH) C18 column (100 mm × 2.1 mm; 1.7 μmparticle diameter). Predicted by Afia on May 17, 2022. Predicted by Afia on May 17, 2022.7.09 minutes32390414
Predicted by Siyang on May 30, 202212.6808 minutes33406817
Predicted by Siyang using ReTip algorithm on June 8, 20221.74 minutes32390414
AjsUoB = Accucore 150 Amide HILIC with 10mM Ammonium Formate, 0.1% Formic Acid61.2 seconds40023050
Fem_Long = Waters ACQUITY UPLC HSS T3 C18 with Water:MeOH and 0.1% Formic Acid2619.5 seconds40023050
Fem_Lipids = Ascentis Express C18 with (60:40 water:ACN):(90:10 IPA:ACN) and 10mM NH4COOH + 0.1% Formic Acid187.9 seconds40023050
Life_Old = Waters ACQUITY UPLC BEH C18 with Water:(20:80 acetone:ACN) and 0.1% Formic Acid178.9 seconds40023050
Life_New = RP Waters ACQUITY UPLC HSS T3 C18 with Water:(30:70 MeOH:ACN) and 0.1% Formic Acid173.5 seconds40023050
RIKEN = Waters ACQUITY UPLC BEH C18 with Water:ACN and 0.1% Formic Acid325.8 seconds40023050
Eawag_XBridgeC18 = XBridge C18 3.5u 2.1x50 mm with Water:MeOH and 0.1% Formic Acid558.1 seconds40023050
BfG_NTS_RP1 =Agilent Zorbax Eclipse Plus C18 (2.1 mm x 150 mm, 3.5 um) with Water:ACN and 0.1% Formic Acid517.9 seconds40023050
HILIC_BDD_2 = Merck SeQuant ZIC-HILIC with ACN(0.1% formic acid):water(16 mM ammonium formate)159.5 seconds40023050
UniToyama_Atlantis = RP Waters Atlantis T3 (2.1 x 150 mm, 5 um) with ACN:Water and 0.1% Formic Acid1142.8 seconds40023050
BDD_C18 = Hypersil Gold 1.9µm C18 with Water:ACN and 0.1% Formic Acid499.1 seconds40023050
UFZ_Phenomenex = Kinetex Core-Shell C18 2.6 um, 3.0 x 100 mm, Phenomenex with Water:MeOH and 0.1% Formic Acid1453.4 seconds40023050
SNU_RIKEN_POS = Waters ACQUITY UPLC BEH C18 with Water:ACN and 0.1% Formic Acid332.5 seconds40023050
RPMMFDA = Waters ACQUITY UPLC BEH C18 with Water:ACN and 0.1% Formic Acid383.8 seconds40023050
MTBLS87 = Merck SeQuant ZIC-pHILIC column with ACN:Water and :ammonium carbonate300.4 seconds40023050
KI_GIAR_zic_HILIC_pH2_7 = Merck SeQuant ZIC-HILIC with ACN:Water and 0.1% FA164.8 seconds40023050
Meister zic-pHILIC pH9.3 = Merck SeQuant ZIC-pHILIC column with ACN:Water 5mM NH4Ac pH9.3 and 5mM ammonium acetate in water41.6 seconds40023050

Predicted Kovats Retention Indices

Underivatized

MetaboliteSMILESKovats RI ValueColumn TypeReference
Prostaglandin F1aCCCCC[C@H](O)\C=C\[C@H]1[C@H](O)C[C@H](O)[C@@H]1CCCCCCC(O)=O4390.6Standard polar33892256
Prostaglandin F1aCCCCC[C@H](O)\C=C\[C@H]1[C@H](O)C[C@H](O)[C@@H]1CCCCCCC(O)=O2759.2Standard non polar33892256
Prostaglandin F1aCCCCC[C@H](O)\C=C\[C@H]1[C@H](O)C[C@H](O)[C@@H]1CCCCCCC(O)=O2911.1Semi standard non polar33892256

Derivatized

Derivative Name / StructureSMILESKovats RI ValueColumn TypeReference
Prostaglandin F1a,1TMS,isomer #1CCCCC[C@@H](/C=C/[C@H]1[C@H](O)C[C@H](O)[C@@H]1CCCCCCC(=O)O)O[Si](C)(C)C2891.7Semi standard non polar33892256
Prostaglandin F1a,1TMS,isomer #2CCCCC[C@H](O)/C=C/[C@H]1[C@H](O[Si](C)(C)C)C[C@H](O)[C@@H]1CCCCCCC(=O)O2780.4Semi standard non polar33892256
Prostaglandin F1a,1TMS,isomer #3CCCCC[C@H](O)/C=C/[C@H]1[C@H](O)C[C@H](O[Si](C)(C)C)[C@@H]1CCCCCCC(=O)O2773.3Semi standard non polar33892256
Prostaglandin F1a,1TMS,isomer #4CCCCC[C@H](O)/C=C/[C@H]1[C@H](O)C[C@H](O)[C@@H]1CCCCCCC(=O)O[Si](C)(C)C2848.1Semi standard non polar33892256
Prostaglandin F1a,2TMS,isomer #1CCCCC[C@@H](/C=C/[C@H]1[C@H](O[Si](C)(C)C)C[C@H](O)[C@@H]1CCCCCCC(=O)O)O[Si](C)(C)C2773.0Semi standard non polar33892256
Prostaglandin F1a,2TMS,isomer #2CCCCC[C@@H](/C=C/[C@H]1[C@H](O)C[C@H](O[Si](C)(C)C)[C@@H]1CCCCCCC(=O)O)O[Si](C)(C)C2773.0Semi standard non polar33892256
Prostaglandin F1a,2TMS,isomer #3CCCCC[C@@H](/C=C/[C@H]1[C@H](O)C[C@H](O)[C@@H]1CCCCCCC(=O)O[Si](C)(C)C)O[Si](C)(C)C2860.3Semi standard non polar33892256
Prostaglandin F1a,2TMS,isomer #4CCCCC[C@H](O)/C=C/[C@H]1[C@H](O[Si](C)(C)C)C[C@H](O[Si](C)(C)C)[C@@H]1CCCCCCC(=O)O2755.7Semi standard non polar33892256
Prostaglandin F1a,2TMS,isomer #5CCCCC[C@H](O)/C=C/[C@H]1[C@H](O[Si](C)(C)C)C[C@H](O)[C@@H]1CCCCCCC(=O)O[Si](C)(C)C2774.3Semi standard non polar33892256
Prostaglandin F1a,2TMS,isomer #6CCCCC[C@H](O)/C=C/[C@H]1[C@H](O)C[C@H](O[Si](C)(C)C)[C@@H]1CCCCCCC(=O)O[Si](C)(C)C2761.3Semi standard non polar33892256
Prostaglandin F1a,3TMS,isomer #1CCCCC[C@@H](/C=C/[C@H]1[C@H](O[Si](C)(C)C)C[C@H](O[Si](C)(C)C)[C@@H]1CCCCCCC(=O)O)O[Si](C)(C)C2749.4Semi standard non polar33892256
Prostaglandin F1a,3TMS,isomer #2CCCCC[C@@H](/C=C/[C@H]1[C@H](O[Si](C)(C)C)C[C@H](O)[C@@H]1CCCCCCC(=O)O[Si](C)(C)C)O[Si](C)(C)C2780.8Semi standard non polar33892256
Prostaglandin F1a,3TMS,isomer #3CCCCC[C@@H](/C=C/[C@H]1[C@H](O)C[C@H](O[Si](C)(C)C)[C@@H]1CCCCCCC(=O)O[Si](C)(C)C)O[Si](C)(C)C2767.2Semi standard non polar33892256
Prostaglandin F1a,3TMS,isomer #4CCCCC[C@H](O)/C=C/[C@H]1[C@H](O[Si](C)(C)C)C[C@H](O[Si](C)(C)C)[C@@H]1CCCCCCC(=O)O[Si](C)(C)C2751.3Semi standard non polar33892256
Prostaglandin F1a,4TMS,isomer #1CCCCC[C@@H](/C=C/[C@H]1[C@H](O[Si](C)(C)C)C[C@H](O[Si](C)(C)C)[C@@H]1CCCCCCC(=O)O[Si](C)(C)C)O[Si](C)(C)C2792.9Semi standard non polar33892256
Prostaglandin F1a,1TBDMS,isomer #1CCCCC[C@@H](/C=C/[C@H]1[C@H](O)C[C@H](O)[C@@H]1CCCCCCC(=O)O)O[Si](C)(C)C(C)(C)C3150.0Semi standard non polar33892256
Prostaglandin F1a,1TBDMS,isomer #2CCCCC[C@H](O)/C=C/[C@H]1[C@H](O[Si](C)(C)C(C)(C)C)C[C@H](O)[C@@H]1CCCCCCC(=O)O2997.7Semi standard non polar33892256
Prostaglandin F1a,1TBDMS,isomer #3CCCCC[C@H](O)/C=C/[C@H]1[C@H](O)C[C@H](O[Si](C)(C)C(C)(C)C)[C@@H]1CCCCCCC(=O)O2995.3Semi standard non polar33892256
Prostaglandin F1a,1TBDMS,isomer #4CCCCC[C@H](O)/C=C/[C@H]1[C@H](O)C[C@H](O)[C@@H]1CCCCCCC(=O)O[Si](C)(C)C(C)(C)C3114.4Semi standard non polar33892256
Prostaglandin F1a,2TBDMS,isomer #1CCCCC[C@@H](/C=C/[C@H]1[C@H](O[Si](C)(C)C(C)(C)C)C[C@H](O)[C@@H]1CCCCCCC(=O)O)O[Si](C)(C)C(C)(C)C3254.0Semi standard non polar33892256
Prostaglandin F1a,2TBDMS,isomer #2CCCCC[C@@H](/C=C/[C@H]1[C@H](O)C[C@H](O[Si](C)(C)C(C)(C)C)[C@@H]1CCCCCCC(=O)O)O[Si](C)(C)C(C)(C)C3257.3Semi standard non polar33892256
Prostaglandin F1a,2TBDMS,isomer #3CCCCC[C@@H](/C=C/[C@H]1[C@H](O)C[C@H](O)[C@@H]1CCCCCCC(=O)O[Si](C)(C)C(C)(C)C)O[Si](C)(C)C(C)(C)C3393.3Semi standard non polar33892256
Prostaglandin F1a,2TBDMS,isomer #4CCCCC[C@H](O)/C=C/[C@H]1[C@H](O[Si](C)(C)C(C)(C)C)C[C@H](O[Si](C)(C)C(C)(C)C)[C@@H]1CCCCCCC(=O)O3209.1Semi standard non polar33892256
Prostaglandin F1a,2TBDMS,isomer #5CCCCC[C@H](O)/C=C/[C@H]1[C@H](O[Si](C)(C)C(C)(C)C)C[C@H](O)[C@@H]1CCCCCCC(=O)O[Si](C)(C)C(C)(C)C3240.5Semi standard non polar33892256
Prostaglandin F1a,2TBDMS,isomer #6CCCCC[C@H](O)/C=C/[C@H]1[C@H](O)C[C@H](O[Si](C)(C)C(C)(C)C)[C@@H]1CCCCCCC(=O)O[Si](C)(C)C(C)(C)C3237.0Semi standard non polar33892256
Prostaglandin F1a,3TBDMS,isomer #1CCCCC[C@@H](/C=C/[C@H]1[C@H](O[Si](C)(C)C(C)(C)C)C[C@H](O[Si](C)(C)C(C)(C)C)[C@@H]1CCCCCCC(=O)O)O[Si](C)(C)C(C)(C)C3467.5Semi standard non polar33892256
Prostaglandin F1a,3TBDMS,isomer #2CCCCC[C@@H](/C=C/[C@H]1[C@H](O[Si](C)(C)C(C)(C)C)C[C@H](O)[C@@H]1CCCCCCC(=O)O[Si](C)(C)C(C)(C)C)O[Si](C)(C)C(C)(C)C3511.2Semi standard non polar33892256
Prostaglandin F1a,3TBDMS,isomer #3CCCCC[C@@H](/C=C/[C@H]1[C@H](O)C[C@H](O[Si](C)(C)C(C)(C)C)[C@@H]1CCCCCCC(=O)O[Si](C)(C)C(C)(C)C)O[Si](C)(C)C(C)(C)C3513.7Semi standard non polar33892256
Prostaglandin F1a,3TBDMS,isomer #4CCCCC[C@H](O)/C=C/[C@H]1[C@H](O[Si](C)(C)C(C)(C)C)C[C@H](O[Si](C)(C)C(C)(C)C)[C@@H]1CCCCCCC(=O)O[Si](C)(C)C(C)(C)C3458.0Semi standard non polar33892256
Prostaglandin F1a,4TBDMS,isomer #1CCCCC[C@@H](/C=C/[C@H]1[C@H](O[Si](C)(C)C(C)(C)C)C[C@H](O[Si](C)(C)C(C)(C)C)[C@@H]1CCCCCCC(=O)O[Si](C)(C)C(C)(C)C)O[Si](C)(C)C(C)(C)C3683.4Semi standard non polar33892256
Spectra

GC-MS Spectra

Spectrum TypeDescriptionSplash KeyDeposition DateSourceView
Predicted GC-MSPredicted GC-MS Spectrum - Prostaglandin F1a GC-MS (Non-derivatized) - 70eV, Positivesplash10-01q0-7379000000-a80bb477130f4920e3f82017-09-01Wishart LabView Spectrum
Predicted GC-MSPredicted GC-MS Spectrum - Prostaglandin F1a GC-MS (4 TMS) - 70eV, Positivesplash10-00c0-8210189000-df23bea8a59fa9bad99c2017-10-06Wishart LabView Spectrum
Predicted GC-MSPredicted GC-MS Spectrum - Prostaglandin F1a GC-MS (Non-derivatized) - 70eV, PositiveNot Available2021-10-12Wishart LabView Spectrum
Predicted GC-MSPredicted GC-MS Spectrum - Prostaglandin F1a GC-MS (Non-derivatized) - 70eV, PositiveNot Available2021-10-12Wishart LabView Spectrum

MS/MS Spectra

Spectrum TypeDescriptionSplash KeyDeposition DateSourceView
Predicted LC-MS/MSPredicted LC-MS/MS Spectrum - Prostaglandin F1a 10V, Positive-QTOFsplash10-00dr-0009000000-ee4ad5913a757d21e80a2017-09-01Wishart LabView Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrum - Prostaglandin F1a 20V, Positive-QTOFsplash10-00dr-3197000000-f2995d281bea49b8f8cb2017-09-01Wishart LabView Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrum - Prostaglandin F1a 40V, Positive-QTOFsplash10-00vl-9160000000-66d373db3994a9b692532017-09-01Wishart LabView Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrum - Prostaglandin F1a 10V, Negative-QTOFsplash10-0a4r-0009000000-a68b82b30b12097121692017-09-01Wishart LabView Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrum - Prostaglandin F1a 20V, Negative-QTOFsplash10-052r-1039000000-0eb2b0c2f394df865d7a2017-09-01Wishart LabView Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrum - Prostaglandin F1a 40V, Negative-QTOFsplash10-0a4i-9631000000-3696ca86fef9e2d7e6c42017-09-01Wishart LabView Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrum - Prostaglandin F1a 10V, Negative-QTOFsplash10-0a4i-0009000000-ca50430fcebead154dce2021-09-24Wishart LabView Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrum - Prostaglandin F1a 20V, Negative-QTOFsplash10-0a4i-0059000000-f1ee0351b4eb7afd7ee22021-09-24Wishart LabView Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrum - Prostaglandin F1a 40V, Negative-QTOFsplash10-0035-6093000000-26f9e8ca80319a0729552021-09-24Wishart LabView Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrum - Prostaglandin F1a 10V, Positive-QTOFsplash10-00dr-0019000000-9fe4f88bef4300069cc62021-09-24Wishart LabView Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrum - Prostaglandin F1a 20V, Positive-QTOFsplash10-00dl-9154000000-e93e360b803128be6ab52021-09-24Wishart LabView Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrum - Prostaglandin F1a 40V, Positive-QTOFsplash10-052f-9400000000-b045babce70118a4fad82021-09-24Wishart LabView Spectrum
Biological Properties
Cellular Locations
  • Extracellular
  • Membrane (predicted from logP)
Biospecimen Locations
  • Blood
  • Feces
Tissue LocationsNot Available
Pathways
Normal Concentrations
BiospecimenStatusValueAgeSexConditionReferenceDetails
BloodDetected and Quantified0.000376 +/- 0.0000317 uMAdult (>18 years old)Both
Normal
details
FecesDetected but not QuantifiedNot QuantifiedAdult (>18 years old)BothNormal details
FecesDetected but not QuantifiedNot QuantifiedChildren (1-13 years old)BothNormal details
Abnormal Concentrations
BiospecimenStatusValueAgeSexConditionReferenceDetails
FecesDetected but not QuantifiedNot QuantifiedAdult (>18 years old)BothCCD details
FecesDetected but not QuantifiedNot QuantifiedAdult (>18 years old)BothIleal Crohn's disease details
Associated Disorders and Diseases
Disease ReferencesNone
Associated OMIM IDsNone
DrugBank IDNot Available
Phenol Explorer Compound IDNot Available
FooDB IDFDB023044
KNApSAcK IDNot Available
Chemspider ID4444441
KEGG Compound IDC06475
BioCyc IDNot Available
BiGG IDNot Available
Wikipedia LinkNot Available
METLIN ID3503
PubChem Compound5280939
PDB IDNot Available
ChEBI ID28852
Food Biomarker OntologyNot Available
VMH IDHC02214
MarkerDB IDNot Available
Good Scents IDNot Available
References
Synthesis ReferenceSchneider, William P.; Murray, Herbert C. Microbiological reduction and resolution of prostaglandins. Synthesis of natural PGF2a and ENT-PGF2b methyl esters. Journal of Organic Chemistry (1973), 38(2), 397-8.
Material Safety Data Sheet (MSDS)Download (PDF)
General References
  1. Beitz J, Forster W: Influence of human low density and high density lipoprotein cholesterol on the in vitro prostaglandin I2 synthetase activity. Biochim Biophys Acta. 1980 Dec 5;620(3):352-5. [PubMed:6786342 ]
  2. Sutton JG, Bosley C, Rands A: The detection by enzyme linked immunosorbent assay of P30 and 19-OH prostaglandin F1/F2, in the presence of a range of possible contaminants. Sci Justice. 1998 Jul-Sep;38(3):157-64. [PubMed:9800431 ]
  3. King SJ, Sutton JG, Trewsdale LA: Radioimmunoassay detection limits for 19-OH F1 alpha/F2 alpha prostaglandin in normal, infertile and vasectomized semen stains. Analysis of saliva, sweat and urine for possible non-specific or matrix effects. Forensic Sci Int. 1989 Mar;40(3):221-9. [PubMed:2471677 ]
  4. O'Neill P, Walton S, Foy PM, Shaw MD: Role of prostaglandins in delayed cerebral ischemia after subarachnoid hemorrhage. Neurosurgery. 1992 Jan;30(1):17-22. [PubMed:1738450 ]
  5. Schweer H, Seyberth HW, Kuhl PG, Meese CO: Unusual metabolism of prostacyclin in infants with persistent septic pulmonary hypertension. Eicosanoids. 1990;3(4):237-42. [PubMed:2073401 ]
  6. Barrow SE, Waddell KA, Ennis M, Dollery CT, Blair IA: Analysis of picomolar concentrations of 6-oxo-prostaglandin F1 alpha in biological fluids. J Chromatogr. 1982 Apr 30;239:71-80. [PubMed:7096507 ]